Citation Impact
Citing Papers
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
2008 Standout
Accelerated telomere shortening in response to life stress
2004 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Immune Responsiveness Following Academic Stress in First-Year Medical Students
2001
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Academic Stress and Secretory Immunoglobulin A
2000
The Role of Maintenance Strategies in Metastatic Colorectal Cancer
2019
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Psychological Stress and Disease
2007 Standout
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
2014
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Individual differences in utilizing control to cope with job demands: Effects on susceptibility to infectious disease.
2001
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Autonomic nervous system activity in emotion: A review
2010 Standout
Odor Hedonics: Connection With Emotional Response Estimated by Autonomic Parameters
1997
Decrease of Suppressor-Inducer (CD4+CD45RA) T Lymphocytes and Increase of Serum Immunoglobulin G due to Perceived Job Stress in Japanese Nuclear Electric Power Plant Workers
2000
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Psychobiology of Altered States of Consciousness.
2005
Taxotere???5???-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells
2005
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Startle reflex modulation by pleasant and unpleasant odors in a between‐subjects design
1997
Job Strain and Anger Expression Predict Early Morning Elevations in Salivary Cortisol
2000
Visual Event Related Potentials Modulated by Contextually Relevant and Irrelevant Olfactory Primes
1999
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
2007
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Engineering lymphocyte subsets: tools, trials and tribulations
2009
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Colorectal cancer
2019 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Chemotherapy Maintenance
2016
The neurochemistry of music
2013 Standout
Oesophageal carcinoma
2013 Standout
Equipoise and the Dilemma of Randomized Clinical Trials
2011
Dynamics of telomerase activity in response to acute psychological stress
2009 StandoutNobel
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
2015
Capecitabine: A review
2005
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Modulation of secretory immunoglobulin A in saliva; response to manipulation of mood
2000
Basic Emotions Evoked by Eugenol Odor Differ According to the Dental Experience. A Neurovegetative Analysis
1999
Prolonged reduction of salivary immunoglobulin A (sIgA) after a major academic exam
2000
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
2007
Responses of the Nervous System to Low Frequency Stimulation and EEG Rhythms: Clinical Implications
1998
Stress-induced immune dysfunction: implications for health
2005 Standout
Pancreatic Cancer
2010 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Effects of Music on the Recovery of Autonomic and Electrocortical Activity After Stress Induced by Aversive Visual Stimuli
2007
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
2005
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
2015
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Stress and secretory immunity
2002
Cardiovascular and secretory immunoglobulin A reactions to humorous, exciting, and didactic film presentations
2000
Molecular pathogenesis of mantle cell lymphoma
2012
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 Standout
ACADEMIC STRESS AND SECRETORY IMMUNOGLOBULIN A
2000
XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer
2004
The ever‐increasing importance of cancer as a leading cause of premature death worldwide
2021 Standout
Vision assessment using the NIH Toolbox
2013 Standout
Combination therapy in combating cancer
2017 Standout
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
2003
Electrophysiology reveals semantic memory use in language comprehension
2000 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
2008
Treatment of a Patient with Advanced Esophageal Cancer with a Combination of Mitomycin C and Capecitabine: Activation of the Thymidine Phosphorylase as Active Principle?
2003
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
2003
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
Tumor-Associated Neutrophils in Cancer: Going Pro
2019
Works of Peter Brauchli being referenced
Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation
2009
Electrocortical and Autonomic Alteration by Administration of a Pleasant and an Unpleasant Odor
1995
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
2005
Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
2012
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
2015
Effects of work demands on immunoglobulin A and cortisol in air traffic controllers
1996
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
2012
Electrocortical, autonomic, and subjective responses to rhythmic audio-visual stimulation
1995
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)
2012
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores
2019
Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal Cancer
2002